Venus Concept Total Liabilities 2016-2025 | VERO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Venus Concept total liabilities from 2016 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Venus Concept Total Liabilities 2016-2025 | VERO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Venus Concept total liabilities from 2016 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$171.9B
Thermo Fisher Scientific (TMO)	$161.4B
Alcon (ALC)	$45.6B
Edwards Lifesciences (EW)	$42B
IDEXX Laboratories (IDXX)	$33.3B
DexCom (DXCM)	$26.9B
IQVIA Holdings (IQV)	$25.4B
STERIS (STE)	$21.8B
Mettler-Toledo (MTD)	$20.9B
Waters (WAT)	$19.1B
SONOVA HOLDING (SONVY)	$17.3B
Fresenius Medical Care AG KGaA (FMS)	$13.9B
Hologic (HOLX)	$12.9B
Sysmex ADR (SSMXY)	$11.8B
Penumbra (PEN)	$10.7B
Globus Medical (GMED)	$9.8B
Masimo (MASI)	$8.2B
Teleflex (TFX)	$6B
Glaukos (GKOS)	$5.2B
Integer Holdings (ITGR)	$4.1B
TransMedics (TMDX)	$3B
PROCEPT BioRobotics (PRCT)	$2.9B
Veracyte (VCYT)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
LivaNova (LIVN)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.5B
Integra LifeSciences Holdings (IART)	$1.2B
Pulse Biosciences (PLSE)	$1.2B
Tandem Diabetes Care (TNDM)	$1.1B